The Division Bench dismissed the connected writ appeals, while making a limited modification to the Single Judge’s findings concerning the Bar Council of Kerala. In light of…
PharmEasy Sells 10% Stake in Thyrocare for INR 668 Cr
Update / Judgement Date
26 Oct 2025
Source
Author
Team — WCP Legal Desk
Reading Time
1 min read
View Count
1
PharmEasy has divested a 10 % stake in Thyrocare Technologies for approximately ₹668 crore. This strategic transaction enables the company to monetise its investment, strengthen liquidity and refocus on core operations, reflecting consolidation and exit dynamics in India’s health-tech and diagnostic sector.